wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24633710-258CF212-CF1A-497B-B34E-0632EED3D5ED
Q24633710-258CF212-CF1A-497B-B34E-0632EED3D5ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-258CF212-CF1A-497B-B34E-0632EED3D5ED
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
P2860
Q24633710-258CF212-CF1A-497B-B34E-0632EED3D5ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-258CF212-CF1A-497B-B34E-0632EED3D5ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
114b32941c4e838a06e57ff04c844d39d96c4860
P2860
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.